Day One Biopharmaceuticals, Inc.
Clinical trials sponsored by Day One Biopharmaceuticals, Inc., explained in plain language.
-
Targeted drug trial offers new hope for kids with brain tumors
Disease control Recruiting nowThis study is testing a new oral drug called tovorafenib (DAY101) against standard chemotherapy for children and young adults with a specific type of slow-growing brain tumor. The goal is to see if the new drug is more effective at shrinking tumors and controlling the disease, an…
Phase: PHASE3 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cancer drug enters human testing for nine tough tumor types
Disease control Recruiting nowThis is the first study in people testing a new experimental drug called DAY301 for advanced cancers that have spread. Researchers will give increasing doses to about 254 patients with specific advanced solid tumors to find the safest dose and see if the drug shows early signs of…
Phase: PHASE1 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC